UT Southwestern Neurology

08/12/2026

From antibody testing to advanced clinical trials, the landscape of care continues to evolve. Diagnosis often involves:

🔬 AChR, MuSK & LRP4 antibody testing
⚡ Specialized nerve & muscle studies
🩻 CT imaging for thymus involvement

UT Southwestern is also enrolling patients in trials investigating CAR T-cell therapy & Telitacicept as potential new treatment approaches for .

Myasthenia gravis is a rare autoimmune disorder. Personalized treatment can help more people have symptom-free days. Learn more.

08/10/2026

Every step brings us closer to a world without Alzheimer's. 💜

The countdown is on for the 2026 Dallas Walk to End Alzheimer's, and the North Texas Alzheimer's Disease Research Center (NT-ADRC) at UT Southwestern is proud to be walking in support of everyone impacted by Alzheimer's disease and related dementias.

Whether you've been personally affected by Alzheimer's, are passionate about brain health, or simply want to make a difference, we'd love for you to join our team!

👟 Why walk with us?
💜 Honor a loved one.
🧠 Support research that brings hope for earlier detection, better treatments, and one day, a cure.
🤝 Stand alongside families, caregivers, researchers, and advocates who are committed to ending Alzheimer's.
🌟 Help raise awareness while making a meaningful impact in our community.

📅 Dallas Walk to End Alzheimer's
Saturday, November 7
📍 Klyde Warren Park

Whether you register to walk, make a donation, or simply share our team page, every action helps move us closer to a future without Alzheimer's.

🔗 Join Team NT-ADRC: UTSW or make a donation today by scanning the QR code on the flyer!

08/07/2026

The North Texas Alzheimer's Disease Research Center, now led by Pedro Rosa-Neto, M.D., Ph.D., is focused on:
🧠 Investigating risk factors, including the role of cardiometabolic health and hypertension in dementia
🤝 Strengthening scientific and clinical collaborations across North Texas and beyond
📚 Expanding education and support for researchers, clinicians, patients, caregivers, and learners

By combining cutting-edge research, clinical trials, biomarker discovery, and community engagement, the NT-ADRC is helping shape the future of dementia care and research.

Since launching in April, the North Texas Alzheimer’s Disease Research Center (NT-ADRC) based at UT Southwestern Medical Center has quickly established the foundation needed to support cutting-edge research into Alzheimer’s and related dementias.

08/06/2026

We are proud to be recognized as a high performing hospital for stroke and to receive the - Stroke Gold Plus & Commitment to Quality awards from .
A round of applause for our entire stroke team who are dedicated to providing evidence-based care
✔ Coordinated care across service lines
✔ Real-time data and results-driven improvement
✔ Better outcomes for the people who count on us

08/05/2026

A big congratulations to Junyeon Won, Ph.D. on being awarded an NIH/NIA K99! The award will support his transition toward an independent research program focused on understanding vascular mechanisms of brain aging and developing early intervention strategies for the prevention of Alzheimer’s disease and related dementias.
https://bit.ly/4hh7EEt

08/04/2026

UT Southwestern is proud to be ranked the No. 1 hospital in DFW for the 10th straight year by U.S. News & World Report, as well as one of the nation’s top 10 centers for neurological care.

07/28/2026

Peter Sguigna, M.D. and the MS & Neuroimmunology team are leveraging advanced imaging technologies such as optical coherence tomography (OCT) to identify signs of neurodegeneration, monitor disease activity, and improve outcomes for patients with multiple sclerosis and related disorders.

Because the retina and optic nerve offer a direct view of the central nervous system, subtle visual changes can reveal underlying neurologic conditions long before other symptoms appear. [physicianr...tswmed.org]
Learn how collaboration between neurology and ophthalmology is helping accelerate diagnosis, personalize care, and advance the search for remyelination therapies.
https://bit.ly/4pLYLFa

The eye is one of the few places in the body where the central nervous system can be observed directly – and it often speaks before the brain does.

07/28/2026

We are proud to recognize our Department of Neurology team members nominated for the 2026 APP Outstanding Achievement Awards and the faculty leaders who champion the growth, development, and success of Advanced Practice Providers across our programs.
👏 APP Nominees
Samantha McCormick, PA (General & Headache Medicine)
Joy Ramos, NP (Sleep Medicine)
Sarah Smith, PA (Movement Disorders)
Sonali Weerasinghe, PA (Neurocritical Care)

👏 APP Champion Nominees
Ben Greenberg, M.D.
Darin Okuda, M.D.
Deepa Sirsi, M.D.
Jay Harvey
Lauren Tardo, M.D.
Congratulations to all of this year's nominees! 🎉

07/23/2026

Lewy body dementia can affect thinking, movement, sleep, mood, and daily functioning, making early recognition critical for patients and caregivers.
Featured in a recent national article on Lewy body dementia, UT Southwestern expertise continues to help educate patients and families about this complex neurodegenerative disorder while advancing research into diagnosis and treatment. Through clinical care and ongoing research efforts, UTSW remains committed to improving outcomes for individuals living with dementia and related disorders.

It’s the second most common type of dementia, but it’s often mistaken for something else.

07/16/2026

🧠 Blood-based biomarker tests are transforming Alzheimer’s care.
New FDA-approved tests can help validate or rule out Alzheimer’s disease in patients with cognitive symptoms, offering greater diagnostic clarity and supporting earlier intervention.

At UT Southwestern, researchers continue to advance the future of personalized dementia diagnosis and treatment.

FDA-approved blood tests for Alzheimer’s disease support more precise diagnoses. See how they work and explore the future of personalized dementia care.